The field of gastroenterology is witnessing an influx of options for treating Crohn’s disease, with promising treatments being trialled. Current personalized treatment plans consider numerous factors and strategies, with biologics forming the medical frontline. Newer biologics and biosimilars have seen surgery rates decrease. Nonetheless, obstacles persist with high costs, complicated causes and diverse disease types frustrating efforts to cure Crohn’s. Despite these challenges, optimism remains high over progress in diagnosing, managing and preventing the condition.
Health Tech | Safeguarding health: Navigating the complex landscape of cybersecurity in healthcare | News
The integration of technology in healthcare, while beneficial, has increased the sector’s vulnerability to cyber threats. Cybercriminals target healthcare data due to its high value,
